drugset
drugset / Trial / NCT05842408

Clinical Trial of DA-5212 in Patients with Functional Dyspepsia

NCT05842408 ↗

Phase 3 Completed 384 enrolled Dong-A ST Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is to evaluate efficacy and safety of DA-5212 in patients with functional dyspepsia

Timeline

Start
2023-06-06
Primary completion
2024-09-04
Completion
2024-09-04

Drugs

EvaluationDrugModalityDoseRoute
Subject DA-5212 Unknown — —
Subject DA-5212-R Unknown — —

Indications

dyspepsia